Prurigo Nodularis Podcasts: Targeted Therapies in the Dawn of a New Era is organized by Healio, Vindico Medical Education.
Release Date: August 31, 2023
Expiration Date: August 30, 2024
Activity Description
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by pruritic, hyperkeratotic nodules typically distributed on the trunk and extremities. In patients with PN, systemic inflammation and neurological dysregulation perpetuate the itch-scratch cycle. In addition to having a profound negative impact on sleep and quality of life, PN is frequently associated with depression, anxiety, and other comorbidities. Conventional management typically involves multimodal therapy with nonspecific immunosuppressants and neuromodulators. Recently approved and emerging therapies that target key inflammatory mediators are significantly shifting treatment paradigms. In this podcast series, faculty experts discuss the pathophysiology of PN and disease burden, the importance of multimodal therapy, as well as the promise of new and emerging therapies designed to disrupt the itch-scratch cycle and improve patient quality of life.
Learning Objective
Upon successful completion of this activity, participants should be better able to:
• Describe the underlying pathophysiology and characteristic features of PN and the effects of chronic itch on patients’ quality of life.
• Review recent scientific findings and clinical trial data supporting the use of current and emerging therapies for PN.
• Recognize the need for comprehensive, personalized, and interprofessional management strategies for PN that incorporate topical and systemic agents to reduce symptoms and improve outcomes.